NCT01985958View on ClinicalTrials.gov

A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2019

Conditions
Histological or Cytological Diagnosis of Pancreatic Carcinoma
Interventions
DEVICE

Radiation therapy

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01985958 - A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas | Biotech Hunter | Biotech Hunter